Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.2M | 2 | 100.0% |
| Food and Beverage | $68.51 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Romark Laboratories, LC | $1.2M | 2 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $68.51 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $18.00 | 1 | Merck Sharp & Dohme Corporation ($18.00) |
| 2018 | $1.2M | 2 | Romark Laboratories, LC ($1.2M) |
| 2017 | $50.51 | 3 | Merck Sharp & Dohme Corporation ($50.51) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/13/2019 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), PIFELTRO, DELSTRIGO | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/15/2018 | Romark Laboratories, LC | Alinia Tablets 500mg 30 count bottle (Drug), Alinia for Oral Suspension, Alinia Tablets 500mg 12 count bottle | — | Cash or cash equivalent | $1,162,569.30 | Research |
| Study: A Phase III Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide and Nitazoxanide Plus Oseltamivir in the Treatment of Acute Uncomplicated Influenza • Category: Gastroenterology | ||||||
| 11/15/2018 | Romark Laboratories, LC | Alinia for Oral Suspension (Drug), Alinia Tablets 500mg 30 count bottle, Alinia Tablets 500mg 12 count bottle | — | Cash or cash equivalent | $20,000.00 | Research |
| Study: Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection • Category: Gastroenterology | ||||||
| 09/18/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/19/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/30/2017 | Merck Sharp & Dohme Corporation | ISENTRESS (Drug), ZEPATIER | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: INFECTIOUS DISEASE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase III Randomized Double-Blind Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide and Nitazoxanide Plus Oseltamivir in the Treatment of Acute Uncomplicated Influenza | Romark Laboratories, LC | $1.2M | 1 |
| Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection | Romark Laboratories, LC | $20,000 | 1 |
About Dr. Thomas Magee, MD
Dr. Thomas Magee, MD is a Internal Medicine healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1619183662.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Magee, MD has received a total of $1.2M in payments from pharmaceutical and medical device companies, with $18.00 received in 2019. These payments were reported across 6 transactions from 2 companies. The most common payment nature is "" ($1.2M).
Practice Information
- Specialty Internal Medicine
- Location Los Angeles, CA
- Active Since 05/15/2007
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1619183662
Products in Payments
- Alinia Tablets 500mg 30 count bottle (Drug) $1.2M
- Alinia for Oral Suspension (Drug) $20,000
- ISENTRESS (Drug) $68.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Los Angeles
Dr. Julio Gutierrez, Md, MD
Internal Medicine — Payments: $920,439
Dr. Mohammad Kamgar, M.d, M.D
Internal Medicine — Payments: $471,176
Dr. Caroline Piatek, M.d,, M.D,
Internal Medicine — Payments: $468,526
Gottfried Konecny, Md, MD
Internal Medicine — Payments: $399,651
Dr. Elizabeth Volkmann, Md, MD
Internal Medicine — Payments: $397,666
Ivan Ho, Md, MD
Internal Medicine — Payments: $378,999